Xu et al. [40] found that serum GP39 levels were elevated in patients with cerebrovascular diseases, and that serum levels of GP39 were significantly lower in healthy control subjects than in patients with acute ischemic or hemorrhagic stroke and transient ischemic attack. This evidence concerns the gene CHI3L1 and transient ischemic attack.